During the past decade, Seoul National University Hospital Clinical Trial Center conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seoul National University Hospital Clinical Trial Center" #1 sponsor was "Seoul National University Hospital" with 24 trials, followed by "Dong-A ST Co., Ltd." with 8 trials sponsored, "HK inno.N Corporation" with 5 trials sponsored, "Yuhan Corporation" with 3 trials sponsored and "Amorepacific Corporation" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seoul National University Hospital Clinical Trial Center" #1 collaborator was "Seoul National University Hospital" with 2 trials as a collaborator, "Dong Wha Pharmaceutical Co. Ltd." with 1 trials as a collaborator, "Fresenius Medical Care Korea" with 1 trials as a collaborator, "Green Cross Corporation" with 1 trials as a collaborator and "Jeil-Kirin Pharmaceutical Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Seoul National University Hospital Clinical Trial Center" are "Healthy" (21 trials), "Type 2 Diabetes Mellitus" (4 trials), "Diabetes Mellitus" (2 trials), "Hand, Foot and Mouth Disease" (2 trials) and "Adverse Drug Event" (1 trials). Many other conditions were trialed in "Seoul National University Hospital Clinical Trial Center" in a lesser frequency.

Most popular intervention types in "Seoul National University Hospital Clinical Trial Center" are "Drug" (48 trials), "Biological" (3 trials), "Device" (2 trials), "Dietary Supplement" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Tegoprazan 50 mg" (3 trials), "DA-1229" (2 trials), "DA-1229_01" (2 trials) and "E+M" (2 trials). Other intervention names were less common.

The vast majority of trials in "Seoul National University Hospital Clinical Trial Center" are 39 trials for "Male" genders and 16 trials for "All" genders.

Currently, there are NaN active trials in "Seoul National University Hospital Clinical Trial Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Seoul National University Hospital Clinical Trial Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Seoul National University Hospital Clinical Trial Center, 42 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 6 trials that are defined as “Not Applicable".